Order Entry
Canada
ContactUsLinkComponent
Tocilizumab ELISA Assay Kit, Actemra®, Eagle Biosciences
Tocilizumab ELISA Assay Kit, Actemra®, Eagle Biosciences
Catalog # 103389-232
Supplier:  Eagle Biosciences
CAS Number:  
Tocilizumab ELISA Assay Kit, Actemra®, Eagle Biosciences
Catalog # 103389-232
Supplier:  Eagle Biosciences
Supplier Number:  IG-AB108
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products, please provide identification that includes your business name and shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of identification are:

  • • Issued document with your organization's Federal Tax ID Number
  • • Government issued document with your organization's Resale Tax ID Number
  • • Any other Government ID that includes the business name and address

Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Host:
  • Primary antibody reactivity:
  • Description:
    Tocilizumab (Actemra ®) ELISA Assay Kit
  • Size:
    1 kit
  • Environmentally Preferable:
  • Cat. no.:
    103389-232

Specifications

About this item

Tocilizumab mAb-based ELISA precisely measures free Tocilizumab in serum and plasma samples.

  • Dynamic Range: 6 - 200 ng/mL
  • Sensitivity: 2 ng/mL
  • Incubation: 2.5 hours

The drug Tocilizumab (trade name Actemra®) is a humanized monoclonal antibody (mAb) that specifically targets both soluble interleukin-6 receptor (sIL-6R) and membrane bound interleukin-6 receptor (mIL-6R) with high affinity, thereby preventing pro-inflammatory effects of IL-6. The specificity of this testsystem is achieved by using a monoclonal antibody (clon IG-7C84) for the coating of the microtiter plate and also as a conjugate. This Eagle Biosciences Tocilizumab ELISA (mAb-based) is developed for the specific measurement of Tocilizumab in sera, plasma and other biological fluids by the advantage of using a site-directed IG-7C84 mouse monoclonal antibody (mAb) specific for Tocilizumab only. Binding of Tocilizumab to the solid phase, pre-coated with IG-7C84, is inhibited by recombinant human interleukin-6 receptor alpha (rh-IL6Ra) in a concentration dependent manner. Therefore, this Tocilizumab ELISA (mAb-Based) measures the free form of Tocilizumab. The choice of specifically measuring the free form allows investigators to analyze the concentration-effect relationship. Due to the use of a mAb as catcher and also as detection reagent this testkit has an unmatched specificty.